Noctua Care selected for the fifth promotion of Prevent2Care Lab
France’s first incubator dedicated to health prevention selects nineteen startups and six associations.
Written by Noctua Care1 min read
PARIS, July 2023. Noctua Care has been selected for the fifth promotion of Prevent2Care Lab, the first French incubator dedicated to health prevention.
Nineteen startups and six associations make up the 2023 cohort. Over nine months, participants receive tailored support in Paris and Lyon, together with privileged access to the sector expertise of the programme’s partners. Prevent2Care Lab is delivered by INCO with Elior Services Santé, the Fondation d’entreprise Ramsay Santé, and the Pfizer Innovation France endowment fund.
Since its creation in 2018, the programme reports 144 startups and associations supported through incubation or funding, more than 700 jobs created, over €110 million raised by the organisations it has backed, and five million lives touched by the solutions supported.
Noctua Care was selected for its work closing the gaps in the cardiovascular care pathway through multidisciplinary support and on-demand care. Selection places the company within a cohort working on early detection and diagnosis, on making prevention accessible everywhere and to everyone, and on non-pharmacological therapies.
Prevention occupies a contested position in the French health system, which remains structurally oriented toward curative care. Ninety percent of French people believe prevention should hold an important place in the system.
Written by
Written by
Noctua Care